Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This clinical pilot trial is intended to evaluate the feasibility, efficacy and safety of
hematopoietic stem cell transplantation (HSCT) from Human Leukocyte Antigen (HLA)-mismatched
related donors for children and young adults with hematologic malignancies who lack a
suitably matched related or unrelated donor. The methodology will be one that has been
successfully utilized in adult patients at Thomas Jefferson University.